FDA 483 - Helena C. Chang, MD - February 20, 2026

Helena C. Chang, MD in Santa Clara, CA, a clinical investigator, was inspected by the FDA. The inspection revealed that the firm failed to maintain complete and accurate accountability records for investigational devices. Specifically, Break Wave Therapy Probes used in a pivotal clinical trial lacked proper disposition records.